293 related articles for article (PubMed ID: 24779708)
21. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.
Dakhlallah D; Batte K; Wang Y; Cantemir-Stone CZ; Yan P; Nuovo G; Mikhail A; Hitchcock CL; Wright VP; Nana-Sinkam SP; Piper MG; Marsh CB
Am J Respir Crit Care Med; 2013 Feb; 187(4):397-405. PubMed ID: 23306545
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of fatty acid synthase attenuates bleomycin induced lung fibrosis by restoring mitochondrial dysfunction in mice.
Shin H; Park S; Hong J; Baek AR; Lee J; Kim DJ; Jang AS; Chin SS; Jeong SH; Park SW
Sci Rep; 2023 Jun; 13(1):9044. PubMed ID: 37270622
[TBL] [Abstract][Full Text] [Related]
23. Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis.
Lam AP; Herazo-Maya JD; Sennello JA; Flozak AS; Russell S; Mutlu GM; Budinger GR; DasGupta R; Varga J; Kaminski N; Gottardi CJ
Am J Respir Crit Care Med; 2014 Jul; 190(2):185-95. PubMed ID: 24921217
[TBL] [Abstract][Full Text] [Related]
24. An acyltransferase controls the generation of hematopoietic and endothelial lineages in zebrafish.
Xiong JW; Yu Q; Zhang J; Mably JD
Circ Res; 2008 May; 102(9):1057-64. PubMed ID: 18388326
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans.
Yu G; Kovkarova-Naumovski E; Jara P; Parwani A; Kass D; Ruiz V; Lopez-Otín C; Rosas IO; Gibson KF; Cabrera S; Ramírez R; Yousem SA; Richards TJ; Chensny LJ; Selman M; Kaminski N; Pardo A
Am J Respir Crit Care Med; 2012 Oct; 186(8):752-62. PubMed ID: 22859522
[TBL] [Abstract][Full Text] [Related]
28. miR-29 is a major regulator of genes associated with pulmonary fibrosis.
Cushing L; Kuang PP; Qian J; Shao F; Wu J; Little F; Thannickal VJ; Cardoso WV; Lü J
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):287-94. PubMed ID: 20971881
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of epimorphin in bleomycin-induced pulmonary fibrosis in mice.
Terasaki Y; Fukuda Y; Ishizaki M; Yamanaka N
Am J Respir Cell Mol Biol; 2000 Aug; 23(2):168-74. PubMed ID: 10919982
[TBL] [Abstract][Full Text] [Related]
30. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
31. Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.
Li X; Kim SE; Chen TY; Wang J; Yang X; Tabib T; Tan J; Guo B; Fung S; Zhao J; Sembrat J; Rojas M; Shiva S; Lafyatis R; St Croix C; Alder JK; Di YP; Kass DJ; Zhang Y
FASEB J; 2020 Aug; 34(8):9884-9898. PubMed ID: 32596871
[TBL] [Abstract][Full Text] [Related]
32. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
33. The acyltransferase LYCAT controls specific phosphoinositides and related membrane traffic.
Bone LN; Dayam RM; Lee M; Kono N; Fairn GD; Arai H; Botelho RJ; Antonescu CN
Mol Biol Cell; 2017 Jan; 28(1):161-172. PubMed ID: 28035047
[TBL] [Abstract][Full Text] [Related]
34. PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis.
Ganzleben I; He GW; Günther C; Prigge ES; Richter K; Rieker RJ; Mougiakakos D; Neurath MF; Becker C
Cell Mol Life Sci; 2019 Dec; 76(23):4783-4794. PubMed ID: 31168659
[TBL] [Abstract][Full Text] [Related]
35. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
Bauer Y; Tedrow J; de Bernard S; Birker-Robaczewska M; Gibson KF; Guardela BJ; Hess P; Klenk A; Lindell KO; Poirey S; Renault B; Rey M; Weber E; Nayler O; Kaminski N
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):217-31. PubMed ID: 25029475
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Absent in Melanoma 2 Inflammasome in Peripheral Blood Mononuclear Cells From Idiopathic Pulmonary Fibrosis Patients Leads to the Release of Pro-Fibrotic Mediators.
Terlizzi M; Molino A; Colarusso C; Donovan C; Imitazione P; Somma P; Aquino RP; Hansbro PM; Pinto A; Sorrentino R
Front Immunol; 2018; 9():670. PubMed ID: 29675024
[TBL] [Abstract][Full Text] [Related]
37. SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.
Tzouvelekis A; Yu G; Lino Cardenas CL; Herazo-Maya JD; Wang R; Woolard T; Zhang Y; Sakamoto K; Lee H; Yi JS; DeIuliis G; Xylourgidis N; Ahangari F; Lee PJ; Aidinis V; Herzog EL; Homer R; Bennett AM; Kaminski N
Am J Respir Crit Care Med; 2017 Feb; 195(4):500-514. PubMed ID: 27736153
[TBL] [Abstract][Full Text] [Related]
38. Exosomal miRNA Let-7 from Menstrual Blood-Derived Endometrial Stem Cells Alleviates Pulmonary Fibrosis through Regulating Mitochondrial DNA Damage.
Sun L; Zhu M; Feng W; Lin Y; Yin J; Jin J; Wang Y
Oxid Med Cell Longev; 2019; 2019():4506303. PubMed ID: 31949877
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.
Yamashita CM; Dolgonos L; Zemans RL; Young SK; Robertson J; Briones N; Suzuki T; Campbell MN; Gauldie J; Radisky DC; Riches DW; Yu G; Kaminski N; McCulloch CA; Downey GP
Am J Pathol; 2011 Oct; 179(4):1733-45. PubMed ID: 21871427
[TBL] [Abstract][Full Text] [Related]
40. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
